Literature DB >> 17729390

Non-HFE haemochromatosis.

Daniel-F Wallace1, V-Nathan Subramaniam.   

Abstract

Non-HFE hereditary haemochromatosis (HH) refers to a genetically heterogeneous group of iron overload disorders that are unlinked to mutations in the HFE gene. The four main types of non-HFE HH are caused by mutations in the hemojuvelin, hepcidin, transferrin receptor 2 and ferroportin genes. Juvenile haemochromatosis is an autosomal recessive disorder and can be caused by mutations in either hemojuvelin or hepcidin. An adult onset form of HH similar to HFE-HH is caused by homozygosity for mutations in transferrin receptor 2. The autosomal dominant iron overload disorder ferroportin disease is caused by mutations in the iron exporter ferroportin. The clinical characteristics and molecular basis of the various types of non-HFE haemochromatosis are reviewed. The study of these disorders and the molecules involved has been invaluable in improving our understanding of the mechanisms involved in the regulation of iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729390      PMCID: PMC4611190          DOI: 10.3748/wjg.v13.i35.4690

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  86 in total

1.  Identification of ferroportin disease in the Indian subcontinent.

Authors:  D F Wallace; P Browett; P Wong; H Kua; R Ameratunga; V N Subramaniam
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

2.  A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.

Authors:  O T Njajou; N Vaessen; M Joosse; B Berghuis; J W van Dongen; M H Breuning; P J Snijders; W P Rutten; L A Sandkuijl; B A Oostra; C M van Duijn; P Heutink
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

3.  Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.

Authors:  V Bach; A Remacha; A Altés; M J Barceló; M A Molina; M Baiget
Journal:  Blood Cells Mol Dis       Date:  2005-10-27       Impact factor: 3.039

4.  The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype.

Authors:  Gérald Le Gac; Virginie Scotet; Chandran Ka; Isabelle Gourlaouen; Laurence Bryckaert; Sandrine Jacolot; Catherine Mura; Claude Férec
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

5.  A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.

Authors:  K E Arden; D F Wallace; J L Dixon; L Summerville; J W Searle; G J Anderson; G A Ramm; L W Powell; V N Subramaniam
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

6.  Genetic heterogeneity underlies juvenile hemochromatosis phenotype: analysis of three families of northern Greek origin.

Authors:  G Papanikolaou; M Papaioannou; M Politou; N Vavatsi; A Kioumi; P Tsiatsiou; P Marinaki; D Loukopoulos; J I Christakis
Journal:  Blood Cells Mol Dis       Date:  2002 Sep-Oct       Impact factor: 3.039

7.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

8.  A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron.

Authors:  Graça Porto; Antonella Roetto; Filomena Daraio; Jorge Pereira Pinto; Susana Almeida; Conceição Bacelar; Elizabeth Nemeth; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2005-10-15       Impact factor: 22.113

9.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

10.  Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.

Authors:  Carmela Lanzara; Antonella Roetto; Filomena Daraio; Silvain Rivard; Romina Ficarella; Hervey Simard; Timothy M Cox; Mario Cazzola; Alberto Piperno; Anne-Paule Gimenez-Roqueplo; Paola Grammatico; Stefano Volinia; Paolo Gasparini; Clara Camaschella
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  30 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

2.  Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation.

Authors:  Ronald L Sham; Pradyumna D Phatak; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2009-07-09       Impact factor: 22.113

3.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

4.  Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis.

Authors:  Jaya P Gnana-Prakasam; Sushma K Reddy; Rajalakshmi Veeranan-Karmegam; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

5.  Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages.

Authors:  Fikret Aydemir; Supak Jenkitkasemwong; Sukru Gulec; Mitchell D Knutson
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

6.  Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.

Authors:  Sara Pelucchi; Raffaella Mariani; Paola Trombini; Sabina Coletti; Matteo Pozzi; Valentina Paolini; Donatella Barisani; Alberto Piperno
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

7.  Increased iron stores correlate with worse disease outcomes in a mouse model of schistosomiasis infection.

Authors:  Cameron J McDonald; Malcolm K Jones; Daniel F Wallace; Lesa Summerville; Sujeevi Nawaratna; V Nathan Subramaniam
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

Review 8.  Mechanistic and regulatory aspects of intestinal iron absorption.

Authors:  Sukru Gulec; Gregory J Anderson; James F Collins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-03       Impact factor: 4.052

9.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

10.  Non-HFE hemochromatosis.

Authors:  Paulo Caleb Júnior de Lima Santos; Carla Luana Dinardo; Rodolfo Delfini Cançado; Isolmar Tadeu Schettert; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.